Close
Current temperature in Boston - 62 °
BECOME A MEMBER
Get access to a personalized news feed, our newsletter and exclusive discounts on everything from shows to local restaurants, All for free.
Already a member? Sign in.
The Bay State Banner
BACK TO TOP
The Bay State Banner
POST AN AD SIGN IN

Trending Articles

Wellness expo brings community support to Roxbury residents

Sarah-Ann Shaw, Boston's reporting legend, 90

Uncle Nearest Premium Whiskey honors first African American Master Distiller’s legacy

READ PRINT EDITION

Smokers gain weight after quitting

LAURAN NEERGAARD

WASHINGTON — Scientists say they have finally discovered why smokers tend to gain some weight when they kick the habit.

It turns out that nicotine can rev up brain cells that normally signal people to stop eating when they are full, researchers report in Friday’s edition of the journal Science.

The weight connection is not huge: On average, quitters gain less than 10 pounds. Still, it is a worry that many smokers cite when asked why they don’t try to quit. Now the question is whether the discovery might lead to better treatments to help them quit without worrying about weight.

Yale University associate research scientist Yann Mineur stumbled onto the connection while studying a nicotine-related substance in mice — and the animals suddenly started eating less.

Nicotine hooks onto a variety of receptors, or docking sites, on the surface of cells. That is how it triggers addiction in one part of the brain.

But when it comes to weight, the Yale research found that both nicotine and the related drug cytisine were activating a different receptor than the one involved in addiction. This one is located on a small set of neurons in the hypothalamus, a region that regulates appetite.

When they gave nicotine to mice without that cellular pathway, it didn’t help them lose weight like it did normal mice.

Smoking causes cancer, heart attacks and a host of other ailments so worry about modest weight gain should not deter someone from quitting. But smokers who do have that concern should try nicotine-based smoking-cessation treatments, said study senior author Marina Picciotto, a Yale professor of psychiatry and neurobiology.

The other drug used in the mouse experiments, cytisine, is sold in Eastern Europe for smoking cessation but not in the U.S., and she would like to see if there is data on the weight of smokers abroad who have used it.

Developing a drug to target only these specific receptors would be difficult, she cautions, because they are also involved in the body’s stress responses in ways that could lead to such side effects as high blood pressure.

Associated Press